Other versions:

(Verbatim name)

ID

(Catalog Number)

ORG

DES

Invalid DOI was provided, please try again

XML
PDF
 
 
Twitter
Facebook
Mendeley
Reddit
Notify a colleague
  • ContentsContents
  • Article InfoArticle Info
  • CiteCite
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • FigsFigs
  • TabsTabs
  • TaxaTaxa
  • RefsRefs
  • CitedCited
  • Article title
  • Abstract
  • Keywords
  • Introduction
  • Methods
    • Study design
    • Induction of Psoriasis
    • Psoriasis Area Severity Index (PASI) score
    • Preparation of Ivermectin ointment 1% w/w
    • Ivermectin and clobetasol combination ointment
    • Outcome measures
    • Baker’s histopathological grading system
    • Light microscopy
    • Analytic procedure
    • Sample size and randomization
    • Statistical analysis
  • Results
    • Scoring for skin Inflammation Severity
    • Histological examination
      • Healthy group
      • Induction
      • Vehicle group
      • Clobetasol group
      • Ivermectin
      • Ivermectin clobetasol
    • Immunochemistry assay
      • Comparison between the healthy group and induced non-treated group in the level of tissue biomarkers (IL-10, IL-17, TNF-a, and VEGF) and histopathological scores (Baker score) and observational score (PASI score)
      • Comparison between the induced non-treated group and Petrolatum group in the level of tissue biomarkers (IL-10, IL-17, TNF-a, and VEGF); histopathological scores (Baker score) and observational score (PASI score)
      • Comparison between induced non-treated group and all induced treated groups regarding tissue biomarkers (IL-10, IL-17, TNF-a, and VEGF)
      • Comparison between induced non-treated group and all induced treated groups regarding histopathological scores (Baker score) and observational score (PASI score)
  • Discussion
  • Limitations of this study
  • Conclusion
  • Ethics approval
  • Funding
  • Data availability
  • Author Contributions
  • References
Subscribe to email alerts for current Article's categories
Powered by